Elantas Beck India Stock Surges 8% on Margin Expansion and 32% Profit Growth
Alex Smith
2 hours ago
Synopsis: Stock that has given a compounded return of 22 percent in the last three years has now announced its Q4CY25 and annual results, reporting revenue growth, margin expansion, a YoY profit rise of more than 30 percent, and a final dividend declaration.
A small-cap stock engaged in manufacturing specialty chemicals for electrical insulation and engineering resin applications surged after announcing its Q4CY25 and annual results. The company reported steady revenue growth, improved operating margins, and strong profit expansion, alongside recommending a final dividend for shareholders.
With a market cap of more than Rs 7,000 Cr, Elantas Beck India Ltd saw its stock hit an intraday high of Rs 9699, which is 8 percent higher than the previous close of Rs 9014. The company stock has given a compounded return of 22 percent in the last three years.
The Q4CY25 Result
In the latest quarterly results, the company has seen its revenue from operations increase by 9 percent YoY, from Rs 197 Cr in Q4CY24 to Rs 215 Cr in Q4CY25, while the QoQ decreased by 1 percent from Rs 217 Cr. The net profits grew by 30 percent YoY, going from Rs 30 Cr in Q4CY24 to Rs 39 Cr in Q4CY25, while the QoQ increased by 8 percent from Q3CY25’s Rs 36 Cr.
The company saw its revenue from operations increase by 13 percent YoY, from Rs 748 Cr in CY24 to Rs 847 Cr in CY25. The net profits for the same period grew by 6 percent YoY, going from Rs 139 Cr to Rs 147 Cr.
The company has a 3-year sales CAGR of 10 percent, while the TTM is at 13 percent. The company’s 3-year profit CAGR is at 18 percent, while the TTM number is at 6 percent. The company also has an ROCE of 21 percent and an ROE of 16 percent.
Additionally, the company also saw a 300 bps increase in its operating profit margin on YoY basis, going from 18 percent in Q4CY24 to the current 21 percent in Q4CY25
Segment-wise revenue and profit split
The Electrical Insulations segment reported revenue of Rs 169 crore in Q4CY25 compared to Rs 158 crore in Q4CY24, reflecting an approximate 7 percent YoY growth. Segment profit rose to Rs 31 crore from Rs 23 crore last year, marking a strong 35 percent YoY increase.
The Engineering & Electronic Resins and Materials segment posted revenue of Rs 46 crore in Q4CY25 versus Rs 40 crore in Q4CY24, delivering around 15 percent YoY growth. Segment profit increased to Rs 13 crore from Rs 11 crore, translating into an approximate 18 percent YoY rise.
Apart from approving and announcing the Q4CY25 results, the company also recommended a final dividend of Rs. 7.50 per fully paid-up equity share of Rs. 10 face value, representing 75 percent of the face value, for the financial year ended December 31, 2025.
Elantas Beck India Ltd is a specialty chemicals manufacturer focused on electrical insulation and industrial coating solutions. The company produces insulating varnishes, resins, compounds, and protective coatings used in motors, transformers, automotive components, and electronics. It serves domestic and global markets, catering to power, renewable energy, and industrial equipment sectors.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Elantas Beck India Stock Surges 8% on Margin Expansion and 32% Profit Growth appeared first on Trade Brains.
Related Articles
Defence stock receives orders worth ₹733 Cr for defence and electronics products
Synopsis:- Shares of a leading defence Navratna PSU rose 2% after securing ₹733...
Why Did Concord Biotech Shares Jump 18% Today? Check the Reason
Synopsis: Concord Biotech shares surged 18% after hitting a 52-week low, driven...
Samhi Hotel Shares Jump 4% After Signing Agreement with Marriott & Westin to Expand Operations
Synopsis: Hotel stock gained over 4% after its subsidiary signed new agreements...
A2Z Infra Engineering Stock Hits 10% Upper Circuit After ₹142 Cr Dues Settlement Plan with Indian Bank
Synopsis: Infra stock hit a 10% upper circuit after the company announced a Rs....